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ABSTRACT
Introduction: One of the commonly used techniques for mutation screening is High Resolution Melting (HRM) anal-
ysis. HRM is a post PCR method that relies on the detection of the fluorescent signals acquired due to the release 
of DNA intercalated dyes upon the melting of dsDNA to ssDNA. The method is simple, inexpensive and does not 
require post PCR-handling, making it suitable for high throughput screening. Methods: This study aimed to develop 
and validate HRM technique for the screening of two disease-associated single nucleotide polymorphisms (SNPs) 
namely BDNF rs6265 and DAT1 rs40184 using a total of 30 gDNA samples. The obtained results were confirmed 
and validated by sequencing.  Results: HRM analysis showed that the predicted genotypes of BDNF rs6265 and 
DAT1 rs40184 among all the gDNA samples were in 100% concordance with the sequencing results, making it an 
accurate and sensitive method for the detection of SNPs.  Conclusions: The application of HRM can accurately deter-
mine the genotype of BDNF rs6265 and DAT1 rs40184 SNPs, making it a promising tool for rapid and high-through-
put screening of targeted SNPs in a large population study.
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INTRODUCTION
The brain derived neurotrophic factor (BDNF) is a 
growth factor and is the most expressed neurotrophin 
in the adult brain (1). Upon the binding of BDNF to 
the receptor tyrosine kinase B (TrkB), pathways such 
as the phosphatidylinositol-3-kinase (PI3K) pathway, 
the phospholipase C (PLCγ) pathway, and the mitogen-
activated protein kinase (MAPK) pathway are activated 
(2,3). The activation of the above pathways results in 
neuronal growth, differentiation, and synaptic plasticity 
and was shown to be crucial to the mechanisms related 
to memory solidation (4,5). BDNF has crucial roles in 
neuronal development and maintenance of both central 
and peripheral nervous system. A single nucleotide 
polymorphism (SNP) in the BDNF gene known as 
rs6265 was found to be associated with the development 
of several mental illnesses such as bipolar disorder, 
Alzheimer’s disease, schizophrenia and depression 
(6–9). The rs6265 results in a substitution of the amino 
acid valine with methionine at codon 66, leading to 
alteration in the secretion of the mature BDNF protein 
(10,11).
Dopamine is a neurotransmitter that regulates several 
body functions such as movement, reward, cognition 
and mood (12). The availability of dopamine is 
regulated by the dopamine transporter (DAT1). DAT1 
is a plasma membrane protein that regulates the 
reuptake of dopamine in the presynaptic neurons (13). 
Deficiency of dopamine has been associated with 
several disorders such as bipolar disorder, Parkinson’s 
disease, schizophrenia and depression implicating a role 
of DAT1 in the aetiology of these disorders (14–17). A 
single nucleotide polymorphism in the 14th intron of the 
dopamine transporter gene, rs40184, has been shown to 
be associated with the development of neuropsychiatric 
disorders such as depression (18), bipolar disorder(19) 
and attention deficit hyperactivity disorder (ADHD) (20). 
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Despite the association to several disorders, to date, 
there is no clear mechanism that explains the role and 
function of this SNP in the development of the disorders 
in humans (21). Studies on mice models, however, 
found that polymorphisms on the DAT1 gene affect the 
normal functionality of the gene, leading to hyperactivity 
and diminished dopaminergic tone (22,23).
One of the most employed techniques for the screening 
of BDNF rs6265 and DAT1 rs40184 is polymerase chain 
reaction-restriction fragment length polymorphism 
(PCR-RFLP) (17,24–26). PCR-RFLP is a technique that 
relies on the use of restriction enzymes to identify the 
sequence of specific regions or motifs of DNA. PCR-
RFLP approach involves the amplification of the targeted 
DNA fragment bearing the variation via PCR and 
subsequently treating the amplicon with an appropriate 
restriction enzyme that results in the formation of 
restricted fragments of variable sizes. These fragments 
are electrophoresed using agarose or polyacrylamide gel 
before being stained for fluorescence visualization upon 
excitation by UV (27). Among the major disadvantages 
of this technique is the requirement for the usage of 
specific endonucleases for the detection of SNPs, which 
limits the range of detectable SNPs. Other disadvantages 
include being laborious, time-consuming and unusable 
for high-throughput screening (28), thus indirectly 
escalating the cost per man-hour production.
An alternative technique to PCR-RFLP is High Resolution 
Melting (HRM).  HRM is a post-PCR method used for 
the detection of several genetic modifications such 
as mutations and single nucleotide polymorphisms 
in the PCR amplified DNA products. The detection is 
achieved through analysing the melting behaviour of 
the nucleic acids via the detection of the fluorescence 
signal of the double-stranded DNA intercalating dye 
(29,30). The analysis of the melting curve is carried 
out by using computer-based software to track the 
melting transition of the PCR product through the 
detection of the change in fluorescence signal as 
the temperature gradually increases and releases the 
saturating dye binding to the double-stranded DNA 
(31). The differentiation of the genotypes is based on 
monitoring changes in the temperature and shape of 
the melting curve. Homozygous (wild-type and mutant) 
genotypes can be discriminated by a slight change in 
the melting temperature, whereas the discrimination of 
heterozygous genotypes is displayed by a change in the 
shape of the melting curve (32). As compared to other 
real-time amplification methods such as TaqMan and 
fluorescence resonance energy transfer, HRM uses low-
cost fluorescent dyes that require minimum optimization 
(33,34).
The purpose of this study was to develop and validate 
HRM assays for the detection of BDNF rs6265 and 
DAT1 rs40184 single nucleotide polymorphisms. The 
assays were optimized for future, rapid and low-cost 
high-throughput screening of samples in 96- or 384-well 
formats in suitable real-time PCR machines.
METHODS
Ethical approval and sample acquisition
Ethical clearance and approval was obtained from 
the Malaysian National Institute of Health (NIH) and 
Medical Research and Ethics Committee (MREC) (ID 
number: NMRR-14-688-19696). Written consent was 
obtained from all the subjects who participated in the 
study. A total of 30 genomic DNA (gDNA) samples were 
obtained for this study.
Genomic DNA preparation
Genomic DNA samples were extracted from the 
buffy coat using QIAamp® DNA Mini Kit (QIAGEN, 
Germany) following the manufacturer’s instructions. 
The quality of the DNA was measured using NanoVue 
Plus UV spectrophotometer (GE Healthcare, USA). 
Only samples with absorbance 260/280 ratio of 1.7-
1.9 were considered pure. The extracted gDNA were 
then electrophoresed using 1% (w/v) agarose gel for 40 
minutes at 100V to measure the integrity. The gel was 
stained with ethidium bromide (Bio-Rad, USA) for 10 
minutes followed by destaining with distilled water. The 
bands were then viewed by G:BOX BioImaging System 
(Syngene, USA). The generation of the gel image was 
obtained by GeneSnap software (Syngene, USA). All the 
DNA samples were stored in -20oC until use.
Primer design and gradient PCR
Primers for the detection of BDNF rs6265 and 
DAT1 rs40184 were designed using Primer3Plus 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/
primer3plus.cgi) and were synthesized by Integrated 
DNA Technologies, Singapore (Table I). To detect the 
optimal annealing temperature, a gradient PCR was 
performed with the temperature ranges between 55oC-
65oC using MasterCycler Gradient Thermal Cycler 
machine (Eppendorf, Germany). The product was 
then electrophoresed using a 2% (w/v) agarose gel for 
60 minutes at 80V to determine the best annealing 
temperature. 
PCR efficiency, specificity, and HRM analysis
Serially diluted PCR amplicons were used to test 
on PCR efficiency and reproducibility using HRM. 
Each 10μl HRM-reaction mixture consisted of 1X 
LightCycler® 480 High Resolution Melting Master 
(Roche, Germany), 15ng of genomic DNA, 0.35 μmol 
forward and reverse primers, 2mM MgCl2 and PCR-
grade water. The reaction was performed in triplication 
on a LightCycler® 480 Multiwell Plate 96 from Roche, 
Germany. The amplification of the SNP was carried 
out using LightCycler® 480 System (Roche,Germany) 
using the following cycle condition: initial denaturation 
at 95oC was done for 10 min followed by 45 cycles of 
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amplification at 95oC for 10s, annealing at 60oC (BDNF 
rs6265) and 61oC (DAT1 rs40184) for 15s, and a final 
extension at 72oC for 10s. Subsequently, amplicons were 
subjected to HRM analysis followed by melting analysis 
in the same machine using a temperature range of 65oC 
to 95oC with 25 acquisitions per every 1oC increment. 
To obtain the best discrimination, validated samples of 
each genotype were included in each run to serve as 
references.
Following HRM, the Light Cycler® released 1.5.1.62SP3 
software was employed to view the real-time 
amplification process and analyse the melting profiles 
of all samples. The normalized melting curves and the 
temperature shifted differential plots were obtained from 
the gene scanning module of the software to determine 
the genotype for each sample based on the profiles of 
validated samples. 
Sequencing
The HRM product of each genotype was purified using 
High Pure PCR purification kit (Roche, Germany) 
following the manufacturer’s instructions and was sent 
for Sanger sequencing using services provided by First 
BASE Laboratories Sdn. Bhd., Malaysia. The assembly 
of the sequences and the generation of the contigs were 
performed by using SNAPGENE software (GSL Biotech; 
available at snapgene.com). A Phred score of >20 was 
used as a cut-off for good quality sequences.
 
RESULTS
Sample preparation and PCR optimization
The quality of DNA is an important criterion for the 
success of HRM. The DNA samples used for this study 
displayed an A260/280 absorbance of 1.7-1.9 indicating 
that the samples were pure. The samples were then 
electrophoresed using 1% (w/v) agarose gel to check the 
integrity of the DNA (Fig.1A). All the bands appeared 
intact above the 10kb marker without smearing 
indicating that the samples were in good gDNA integrity 
and not degraded. 
In this study, primers were designed to amplify the 
targeted sequence of the BDNF and DAT1 genes 
including both rs6265 and rs40184 SNPs, respectively. 
The best annealing temperature was determined by a 
clear and bright gel electrophoresis band with a specific 
product. Based on the gel electrophoresis result, the 
best annealing temperature for BDNF rs6265 and for 
DAT1 rs40184 was determined at 60oC (Fig.1B) and 
61oC, respectively (Fig.1C). A standard curve was then 
obtained to evaluate the efficiency of the PCR for both 
primers (Fig.1D and Fig.1E). Based on the equation 
derived from the standard curve, the PCR efficiency for 
BDNF rs6265 was 99.71% and for DAT1 rs40184 was 
92.37%. R-squared values for both PCR assays were 
greater than 0.98 indicating that the assays were highly 
reproducible.
Validation of HRM specificity
Distinct peaks were obtained for the three genotypes 
(wild-type, heterozygous, and recessive) of BDNF rs6265 
(Fig.2A and Fig.2B) and DAT1 rs40184 (Fig.2C and 
Fig.2D) using high resolution melting. The distinction 
was based on the shape of the melting curve and on 
the melting temperature differences. The difference in 
the plot observed in Fig.2C occured because of the GC 
rich nature of the DAT1 amplicon. Due to their stable 
properties, the GC rich region only melt when a sufficient 
high temperature is reached, resulting in a shoulder 
peak.  To evaluate the accuracy of the HRM method, 
the HRM results were compared to the results obtained 
from Sanger sequencing for BDNF rs6265 (Fig.2E) and 
DAT1 rs40184 (Fig.2F). The electropherogram displayed 
a single peak for the wild-type genotype (GG) and the 
mutant genotype (AA). A distinct overlapping double 
peaks of different colours corresponding to two different 
bases indicated the heterozygous genotype (GA). All the 
30 samples for each SNP were sequenced and matched 
100% with the genotypes predicted by HRM analysis for 
both BDNF rs6265 and DAT1 rs40184.
 
DISCUSSION 
One of the several approaches for the detection of single 
nucleotide polymorphism is the High Resolution Melting 
(HRM) analysis. It is a cheap and rapid SNP detection 
technique that is easy to setup and requires shorter time 
and minimum optimization of the saturating double-
stranded DNA binding dyes (34). A major advantage 
of this technique is that the method uses the normal 
PCR reagents with double-stranded DNA intercalating 
dye and needs no post PCR handling which is very 
convenient for daily diagnostic and screening settings 
(35,36). The HRM technique undergoes the normal step 
of PCR amplification of a DNA template intercalated to 
a binding dye with an additional melting step. Following 
the amplification, the dyes fluoresce at a high level which 
slowly reduces as the DNA dissociates due to melting. 
Table I: The properties of the designed primers for high resolution melting assays.
SNP Primer sequence (5’→3’) GC% /
Tm (oC)
Amplicon
size (bp)
BDNF 
rs6265
Forward CTTGACATCATTGGCTGACACT 45.5/60.2 146
Reverse GCTCCAAAGGCACTTGACTACT  50.0/ 60.0 146
DAT1 
rs40184
Forward CACAGTCTCGCGGCTTTT 55.6/ 60.1 100
Reverse TGGACCAACACACCCTTGA 52.6 / 61.0 100
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Figure 1: (A) A representative image of agarose gel electrophoresis to determine DNA integrity of 12 samples. (B) The 
optimization of the PCR annealing temperature for BDNF rs6265 primers. (C) The optimization of the PCR annealing 
temperature for DAT1 rs40184. The gradient PCR for both primers was performed with the annealing temperature 
ranges between 55-66oC (1=55.0oC, 2=55.7oC, 3=56.6oC, 4=57.8oC, 5=59.1oC, 6=60.5oC, 7=61.8oC, 8=63.1oC, 
9=64.2oC, 10=65.0oC) (D) The standard curve demonstrating the PCR efficiency of BDNF rs6265 at 99.7% (E) The 
standard curve demonstrating the PCR efficiency of DAT1 rs40184 at  92.37%.
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Figure 2: (A) A representative result of the temperature shifted difference plot and (B) the normalized melting curves 
of BDNF rs6265. (C) A representative result of the temperature shifted difference plot and (D) the normalized melting 
curves of DAT1 rs40184. (E) A representative result for the three genotypes obtained from the sequencing of BDNF 
rs6265 and (F) DAT1 rs40184
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Product length, sequence, and GC content are some of 
the factors that play role in the melting behavior. One 
of the criteria to increase the sensitivity of the technique 
is through the usage of a shorter amplicon to broaden 
the variation among the melting profiles (32). As the 
amplicon length decreases, the difference in the melting 
temperature among the different genotypes increases 
resulting in a better profile differentiation. In addition, 
smaller amplicons would possibly reduce the cycling 
times as the denaturation occurs at a lower temperature 
(30).
In this paper, HRM assays were developed and validated 
for the screening of BDNF rs6265 and DAT1 rs40184 
using genomic DNA samples. As shown in Figure 2 
A-D, three genotypes existed for both BDNF rs6265 
and DAT1 rs40184 that demonstrated distinct profiles 
making them distinguishable from each other. The wild-
type and the mutant genotypes were distinguishable from 
each other by analysing the difference in the melting 
temperature, which was predominantly determined 
by the energy needed to break up all the hydrogen 
bonds to completely separate the double-stranded 
DNA into single-stranded. The G-C base pairing (three 
hydrogen bonds) had a higher melting temperature as 
compared to A-T (two hydrogen bonds) base pairing, 
whereas heterozygous samples were differentiated by 
a curve with a distinct shape due to the occurrence of 
mismatching or formation of heteroduplexes during the 
DNA denaturation-reannealing process (35). 
The validation of the HRM results was conducted by 
Sanger sequencing. All the results obtained from the 
HRM agreed with the sequencing results indicating 
that the HRM method is 100% accurate and specific in 
detecting different genotypes for BDNF rs6265 and DAT1 
rs40184. Apart from Sanger sequencing, other methods 
that can be used for measuring the accuracy of the HRM 
include pyrosequencing, microarrays and the usage of 
restriction enzymes and hybridization labelled probe, 
which despite being costly are still equally advisable to 
be used for the determination of the accuracy (37,38).
CONCLUSION
High resolution melting assays were successfully 
developed and validated for the detection of two SNPs 
namely BDNF rs6265 and DAT1 rs40184. Comparing 
the HRM result to the result obtained from sequencing 
shows that this technique is reliable and accurate for 
high-throughput screening approach. As compared 
to other methods, this method has the advantage of 
being easy, efficient and rapid. The use of HRM for the 
screening of SNP enables the elimination of additional 
sequencing analysis that in most cases is costly, involves 
multi-steps, and is time-consuming. 
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